TBPH
Theravance Biopharma Inc
Price:  
8.98 
USD
Volume:  
237,245.00
Cayman Islands | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

TBPH Probability of Bankruptcy

The Probability of Bankruptcy of Theravance Biopharma Inc (TBPH) is 26.24% . This number represents the probability that TBPH will face financial distress in the next 24 months given its current fundamentals and market conditions.

Multiple factors are taken into account when calculating TBPH's probability of bankruptcy : Altman Z-score, Beneish M-score, financial position, macro environments, academic research about distress risk and more.

TBPH - ESG ratings

ESG ratings are directly linked to the cost of capital and TBPH's ability to raise funding, both of which can significantly affect the probability of Theravance Biopharma Inc going bankrupt.

ESG Score 51.00
Environment Score 58.57
Social Score 22.05
Governance Score 72.39
Returns
Historical Returns (5 day) -7.41%
Historical Returns (MTD) 8.06%
Historical Returns (YTD) -18.86%
Historical Returns (13 week) 2.24%
Historical Returns (26 week) -11.46%
Historical Returns (52 week) -16.86%
Efficiency
Asset Turnover 0.15
Receiveable Turnover 4.56
Gross Margin 100.00%
Operating Margin -77.27%
Pretax Margin -71.72%
Net Margin -80.42%
Return on Asset (ROA) -11.10
Return on Equity (ROE) -18.97
Return on Investments (ROI) -18.97
Price Metrics
Market Cap (M) 436.07
Enterprise Value (M)
52 Week High 11.71
52 Week Low 8.21
Beta 0.38
Average Volume (10 day) 0.31
Average Volume (3 month) 0.38
Price / Earnings (P/E)
Price / Sales (P/S) 7.38
Earnings
EPS -0.86
Revenue CAGR (5 year) -1.01%
Risk
Current Ratio 5.74
Quick Ratio 5.29